Osteocalcin-thymidine kinase gene therapy | Interleukin Related interleukin-related.com

Product Name :
Osteocalcin-thymidine kinase gene therapy

Search keywords :
Osteocalcin

drugId :
null

Target Vo:
Thymidine phosphorylase

Target Vo Short Name :
TYMP

Moa_Name:
Thymidine phosphorylase stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Bone Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NMDAR1 Antibody
Dnmt3a Antibody
VGluT1 Antibody: VGluT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa. It can be used for WB assays in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts